By Memorial Sloan-Kettering | Friday, December 28, 2012
Dr. Barakat explains the latest surgical techniques for improving outcomes and quality of life in women with cervical, ovarian, and other gynecologic cancers.
By Julie Grisham, MS, Science Writer/Editor | Thursday, December 27, 2012
Problems with cognitive function can significantly impact a person’s quality of life after cancer treatment. New research is focused on the link between cancer treatment and cognitive changes.
In the Clinic
By Jim Stallard, MA, Writer/Editor | Friday, December 21, 2012
Memorial Sloan-Kettering researchers have shown for the first time that administering a growth factor called interleukin-7 can help patients regenerate T cells more quickly after stem cell transplantation.
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor | Wednesday, December 19, 2012
Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.
In the Lab
By Julie Grisham, MS, Science Writer/Editor | Tuesday, December 18, 2012
Memorial Sloan-Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.
By Andrea Peirce, BA, Writer/Editor | Monday, December 17, 2012
By mid-December 2012, sunscreen products on store shelves in the United States must meet stricter labeling regulations. Dr. Wang answers key questions on this topic.
By Eva Kiesler, PhD, Science Writer/Editor | Friday, December 14, 2012
Recent findings by Memorial Sloan-Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer.
By Media Staff | Wednesday, December 12, 2012
Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.
By Eva Kiesler, PhD, Science Writer/Editor | Tuesday, December 11, 2012
Methods to generate stem cells have given scientists new ways to study some diseases and identify potential drugs, and could one day be used to rebuild diseased or damaged tissues in patients.
By Media Staff | Monday, December 10, 2012
Memorial Sloan-Kettering advanced practice nurses Elizabeth Grahn and Ethel Law have been recognized for their extraordinary achievements in education and research.
By Media Staff | Saturday, December 8, 2012
Charles Sawyers, Chair of Memorial Sloan-Kettering’s Human Oncology and Pathogenesis Program, is widely recognized as someone who is revolutionizing the molecular treatment of cancer.
By Memorial Sloan-Kettering | Friday, December 7, 2012
Memorial Sloan-Kettering experts add to their knowledge of vemurafenib, a drug recently approved by the FDA to treat some patients with metastatic melanoma.
By Allyson Collins, MS, Science Writer/Editor | Thursday, December 6, 2012
The initiative, focused on investigators from Memorial Sloan-Kettering’s Geoffrey Beene Cancer Research Center, highlights the critical need for funding scientific research.
By Esther Napolitano, BS, Science Writer/Editor | Wednesday, December 5, 2012
New, potentially practice-changing research sheds light on the long-term benefits of estrogen-blocking tamoxifen therapy in women with early-stage breast cancer whose disease is estrogen-receptor positive.
By Memorial Sloan-Kettering | Monday, December 3, 2012
Memorial Sloan-Kettering physicians and nurses take their knowledge and expertise overseas.